Heart-imaging specialist VentriPoint Diagnostics Ltd (CVE:VPT) has closed the second and final tranche of its previously announced placing, raising more than C$511,000.
The group issued around 2.43mln units at C$0.21 each for gross proceeds of $511,499.94. In total, the firm raised gross proceeds of C$1,011,499.94 under the placing.
Proceeds will be used for sales and marketing, development and general working capital, Ventripoint said. Each unit consists of one Ventripoint share, and one-half of a share warrant. Each whole warrant will entitle the bearer to buy one further share at US$0.34 each for two years after the issue.
Chief executive Dr George Adams subscribed for 1.5mln units, the company said in the regulatory filing.